[The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems]
- PMID: 1433971
[The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems]
Abstract
Functional pleiotropy and redundancy are characteristic features of cytokines. To understand the signaling mechanisms of such cytokines, we have proposed a two-chain interleukin-6 receptor (IL-6-R) model: IL-6 triggers the association of a ligand-binding chain (IL-6-R) and a non-binding signal transducer (gp130) to form a high-affinity receptor complex, causing transmission of the signal by the cytoplasmic portion of gp130. This model would explain the functional redundancy of cytokines if we were to assume that gp130 interacts with several different receptor chains. Here we present data indicating that gp130 functions as a common signal transducer for IL-6, oncostatin M (OM), leukemia inhibitory factor (LIF), and ciliary neurotrophic factor (CNTF). We show that anti-gp130 monoclonal antibodies completely block the biological responses induced by all of these factors. Since LIF functions as a cholinergic differentiation factor in nerve cells as does CNTF, these results suggest that gp130 may also play a role in the neural system.
Similar articles
-
Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10998-1001. doi: 10.1073/pnas.89.22.10998. Proc Natl Acad Sci U S A. 1992. PMID: 1438305 Free PMC article.
-
AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.J Clin Invest. 1995 Sep;96(3):1319-27. doi: 10.1172/JCI118167. J Clin Invest. 1995. PMID: 7657807 Free PMC article.
-
Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.Cytokine. 1997 Apr;9(4):233-41. doi: 10.1006/cyto.1996.0159. Cytokine. 1997. PMID: 9112331
-
Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.Stem Cells. 1994 May;12(3):262-77. doi: 10.1002/stem.5530120303. Stem Cells. 1994. PMID: 8075593 Review.
-
[Advances in interleukin-6 therapy].Rinsho Byori. 1999 Apr;47(4):321-6. Rinsho Byori. 1999. PMID: 10340005 Review. Japanese.
Cited by
-
Is IL-6 both a cytokine and a neurotrophic factor?J Exp Med. 1996 Jun 1;183(6):2417-9. doi: 10.1084/jem.183.6.2417. J Exp Med. 1996. PMID: 8676061 Free PMC article. Review. No abstract available.
-
A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer.Cancer. 2020 Aug 1;126(15):3464-3470. doi: 10.1002/cncr.32964. Epub 2020 May 26. Cancer. 2020. PMID: 32453456 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials